Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.62 USD | +0.08% | -0.24% | +3.95% |
04-30 | Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies | MT |
04-25 | H.C. Wainwright Adjusts Price Target on Evotec to $11 From $14, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+3.95% | 0 | |
+2.90% | 12.53B | |
+10.78% | 9.46B | |
+10.40% | 5.66B | |
-3.76% | 5.38B | |
+7.80% | 5.3B | |
+10.77% | 4.35B | |
+14.15% | 4.35B | |
+1.77% | 4.07B | |
+5.13% | 3.91B |
- Stock Market
- Equities
- EVO Stock
- News Eaton Vance Ohio Municipal Income Trust
- HC Wainwright Initiates Evotec With Buy Rating, Sets Price Target at $12